Form EFFECT Ambrx Biopharma Inc.
- Indexes close up more than 1% as investors assess Fed news
- China Tells Local Authorities to Prepare For a 'Possible Storm' and Prevent Unrest as Evergrande Crisis Unravels - WSJ
- Salesforce (CRM) Raises FY22 Revenue Guidance; Initiates FY23 Revenue
- Oil prices rise, hit 2-month highs on supply worries
- IDFA Seen as a 'Real Headwind' for Facebook (FB) but Analysts Remain Positive
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
|SECURITIES AND EXCHANGE COMMISSION|
|Washington, D.C. 20549|
|Notice of Effectiveness|
|Effectiveness Date:||June 17, 2021 5:30 P.M.|
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Portfolio Update
- DRAWDOWN OF THE SECOND ADVANCE PURSUANT TO FINANCING ARRANGEMENT BETWEEN VALOE CORPORATION AND RIVERFORT
- Algenex’ CrisBio® platform validated by EU and UK marketing authorization for CrisBio-based vaccine for Rabbit Viral Haemorrhagic Disease
Create E-mail Alert Related CategoriesSEC Filings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!